Ashland AI Stock Analysis
Ashland (AHT) AI Stock Analysis
Ashland
(Frankfurt:AHT)
No summary available
Ashland (AHT) vs. iShares MSCI Germany ETF (EWG)
- Market Cap
- EUR 3.50B
- Dividend Yield
- 2.04%
- Average Volume (3M)
- 433
- Price to Earnings (P/E)
- 849.7
- Beta (1Y)
- 0.60
- Revenue Growth
- -2.93%
- EPS Growth
- ―
- Country
- Germany
- Employees
- 2,800
- Sector
- Basic Materials
- Sector Strength
- 61
- Industry
- Chemicals - Specialty
Ashland Business Overview & Revenue Model
Company Description
Ashland Inc. operates as a global supplier of specialized chemicals and additives. Its business activities are structured into four main divisions: Life Sciences; Personal Care & Household; Specialty Additives; and Intermediates and Solvents. The Lif...
Ashland Earnings Call Summary
The call was predominantly positive. Ashland reported broad-based sales and volume growth, strong performance in Life Sciences and Personal Care, improving Intermediates profitability, substantial cash generation, strategic initiative outperformance, and a constructive fiscal 2027 outlook. These strengths were partially offset by Specialty Additives profitability pressure from Hopewell, soft construction and energy and resources markets, foreign-currency headwinds, higher planned capital expenditures, and lower expected free cash flow conversion.
Q4-2026 Updates
Positive Updates
Negative Updates
Company Guidance
For fiscal 2027, Ashland expects sales of $1.905 billion-$1.975 billion, adjusted EBITDA of $405 million-$435 million, ongoing free cash flow conversion greater than 40% of adjusted EBITDA, capital expenditures of up to approximately $140 million, and approximately $10 million of net productivity and manufacturing optimization benefits; globalize and innovate are targeted to contribute approximately $20 million and $45 million of incremental sales, respectively, representing a 25% increase in the combined incremental sales versus 2026, while foreign currency is expected to create headwinds of approximately $20 million-$25 million in sales and $7 million-$10 million in Adjusted EBITDA. Demand in Life Sciences and Personal Care is expected to remain resilient, Coatings and Performance Specialties are expected to build on recent commercial momentum, Hopewell output is expected to increase by about 25% roughly in fiscal 2027 with another order of magnitude similar in the following year, and over time free cash flow is expected to be greater than 50% relative to adjusted EBITDA.
Ashland Risk Analysis
Ashland disclosed 18 risk factors in its most recent earnings report. Ashland reported the most risks in the "Production" category.
Latest Risks Added
0 New RisksAshland Peers Comparison
Overall Rating
IOSP72Outperform
FUL68Neutral
EMN65Neutral
ESI62Neutral
SCL55Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 72Outperform | $1.98B | 14.15 | 10.42% | 2.23% | 4.73% | ― | |
| 68Neutral | $2.65B | 13.54 | 9.51% | 1.97% | 1.48% | 72.33% | |
| 65Neutral | $7.44B | 11.47 | 10.63% | 5.17% | 0.40% | -6.58% | |
| 62Neutral | $8.03B | 39.14 | 7.39% | 0.97% | 39.62% | -14.83% | |
| Sector * | 61Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
| 55Neutral | $1.51B | 349.37 | 0.36% | 2.38% | 10.02% | -90.50% |
* Basic Materials Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| DE:AHT | Ashland Global Holdings, Inc. | 67.00 | 24.02 | 55.87% | |
| EMN | Eastman Chemical Company | 65.03 | 10.28 | 18.77% | |
| FUL | H.B. Fuller Company | 49.29 | -6.04 | -10.91% | |
| IOSP | Innospec | 80.39 | 9.03 | 12.65% | |
| SCL | Stepan Company | 66.38 | 24.98 | 60.33% | |
| ESI | Element Solutions | 33.08 | 8.38 | 33.91% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
